This inventor holds 2 USPTO granted patents and 7 published patent applications and 1 EPO patent. Top assignee: Genentech, Inc.. Active years: 2008-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008-2013
Title: Rene Bruno - Innovator in HER Antibody Dosing
Introduction
Rene Bruno is a notable inventor based in Marseilles, France. He has made significant contributions to the field of biotechnology, particularly in the development of HER antibodies. With a total of 2 patents to his name, his work has the potential to impact cancer treatment protocols.
Latest Patents
Rene Bruno's latest patents focus on the fixed dosing of HER antibodies, specifically Pertuzumab. This innovation aims to streamline the administration of these critical therapeutic agents, enhancing their effectiveness and patient compliance.
Career Highlights
Rene is currently employed at Genentech, Inc., a leading biotechnology company known for its pioneering work in pharmaceuticals. His role at Genentech allows him to collaborate with some of the brightest minds in the industry, contributing to groundbreaking advancements in medical science.
Collaborations
Rene has worked alongside esteemed colleagues such as David E. Allison and Jian-Feng Lu. Their combined expertise fosters a collaborative environment that drives innovation and research in the field of HER antibodies.
Conclusion
Rene Bruno's contributions to the field of biotechnology, particularly in HER antibody dosing, highlight his role as an influential inventor. His work at Genentech, along with his collaborations, positions him as a key player in advancing cancer treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile